Nick Rodgers
Director/Board Member chez CAMBRIDGE COGNITION HOLDINGS PLC
Fortune : 76 957 $ au 31/03/2024
Profil
Philip Nicholas Rodgers is the founder of Plutus Resources Plc, which was founded in 2005.
He held the title of Chief Executive Officer & Executive Director from 2012 to 2013.
His current job(s) include Chairman at Sehta Enterprises Ltd., Director at Cambridge Meditech Ltd., Secretary, Financial Director & Director at Productiv Ltd.
since 2011, Independent Non-Executive Director at Cambridge Cognition Holdings Plc starting in 2024, Director at Burvale Corporate Governance Advisory Ltd., Director at Quickend Ltd., and Director at Nick Rodgers Financial Ltd.His former job(s) include Non-Executive Chairman at Destiny Pharma Plc from 2018 to 2023, Non-Executive Director at Oxford Biomedica Plc from 2004 to 2016, Corporate Finance Director at Southampton Asset Management Ltd.
from 2005 to 2007, Non-Executive Director at Morvus Technology Ltd., Director at Medermica Ltd., Non-Executive Director at TMO Renewables Ltd., Director at IPSol Energy Ltd., Accountant at Ernst & Young LLP, Head-Life Sciences & Corporate Finance at Evolution Securities Ltd.
from 1989 to 2003, and Principal at Beeson Gregory Ltd.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
DESTINY PHARMA PLC
0,25% | 26/05/2023 | 238 901 ( 0,25% ) | 76 957 $ | 31/03/2024 |
Postes actifs de Nick Rodgers
Sociétés | Poste | Début |
---|---|---|
CAMBRIDGE COGNITION HOLDINGS PLC | Director/Board Member | 01/02/2024 |
Anciens postes connus de Nick Rodgers
Sociétés | Poste | Fin |
---|---|---|
DESTINY PHARMA PLC | Chairman | 19/07/2023 |
OXFORD BIOMEDICA PLC | Chairman | 01/02/2016 |
Southampton Asset Management Ltd.
Southampton Asset Management Ltd. Investment ManagersFinance Southampton Asset Management Ltd (SAM) is a venture capital firm, a subsidiary of University of Southampton Holdings Ltd. The firm is headquartered in Southampton, United Kingdom. | Chief Investment Officer | 27/04/2007 |
Evolution Securities Ltd. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
OXFORD BIOMEDICA PLC | Health Technology |
DESTINY PHARMA PLC | Health Technology |
CAMBRIDGE COGNITION HOLDINGS PLC | Technology Services |
Entreprise privées | 6 |
---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Southampton Asset Management Ltd.
Southampton Asset Management Ltd. Investment ManagersFinance Southampton Asset Management Ltd (SAM) is a venture capital firm, a subsidiary of University of Southampton Holdings Ltd. The firm is headquartered in Southampton, United Kingdom. | Finance |
Evolution Securities Ltd. | Finance |
TMO Renewables Ltd.
TMO Renewables Ltd. BiotechnologyHealth Technology TMO Renewables Ltd. provides biological technology services. It is a unique high-temperature bio-ethanol process boasts high efficiencies and fast conversion rates. The company capable includes utilizing all of the sugars, such as complex longer-chain forms. The firm has built cellulosic ethanol process demonstration unit, which integrates all the necessary steps in a continuous ethanol production process. TMO Renewables was founded in 2002 and is headquartered in Guildford, the United Kingdom. | Health Technology |
Beeson Gregory Ltd. | Finance |
Morvus Technology Ltd.
Morvus Technology Ltd. Pharmaceuticals: GenericHealth Technology Morvus Technology Ltd. discovers, develops and commercializes of novel drugs and technologies in the oncology field. Its products include clinical candidates, research portfolio and non-core programmes. The company was founded by Philip John Burke and Roger Geoffrey Melton in April 2004 and is headquartered in Carmarthen, the United Kingdom. | Health Technology |